Biography
Petrina Kamya, Ph.D., is the Global Business Development Director for Insilico Medicine’s end-to-end AI-driven drug discovery platform, Pharma. AI. Before joining Insilico, Dr. Kamya was at Chemical Computing Group (CCG) and Certara. At CCG, she led the sales and business development of molecular modeling software for pharma and biotech companies and academia. At Certara, she consulted with pharma companies on Market Access strategy. During the pandemic, investment banks and management consulting firms turned to Dr. Kamya to provide due diligence on AI-driven drug discovery platform companies. She became very familiar with many of the key players in the space. She saw the potential these companies, including InSilico Medicine, could have in the optimization of the drug discovery and development process. She joined the InSilico Medicine team in August 2020, where she works closely with drug discovery stakeholders interested in implementing AI-driven computer-aided techniques into their discovery pipelines.